Literature DB >> 18783938

HMGA1 protein is a novel target of the ATM kinase.

Francesca Pentimalli1, Dario Palmieri, Roberto Pacelli, Corrado Garbi, Rossano Cesari, Eric Martin, Giovanna Maria Pierantoni, Paolo Chieffi, Carlo Maria Croce, Vincenzo Costanzo, Monica Fedele, Alfredo Fusco.   

Abstract

The high mobility group HMGA1 protein belongs to a family of architectural factors that play a role in chromosomal organisation and gene transcription regulation. HMGA1 overexpression represents a common feature of human malignant tumours and is causally associated with neoplastic transformation and metastatic progression. Recently, HMGA1 expression has been correlated with the presence of chromosomal rearrangements and suggested to promote genomic instability. Here, we report a novel interaction between HMGA1 protein and the ataxia-telangiectasia mutated (ATM) kinase, the major key player in the cellular response to DNA damage caused by several agents such as ionising radiation (IR). We identified an SQ motif on HMGA1, which is effectively phosphorylated by ATM in vitro and in vivo. Interestingly, confocal microscopy revealed that HMGA1 colocalises with the activated form of ATM (ATM S1981p). Moreover, HMGA1 ectopic expression decreases cell survival following exposure to IR as assessed by clonogenic survival in MCF-7 cells, further supporting the hypothesis that HMGA1 might act as a downstream target of the ATM pathway in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783938     DOI: 10.1016/j.ejca.2008.07.033

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  The Linker Histone GH1-HMGA1 Is Involved in Telomere Stability and DNA Damage Repair.

Authors:  Cyril Charbonnel; Oleh Rymarenko; Olivier Da Ines; Fatiha Benyahya; Charles I White; Falk Butter; Simon Amiard
Journal:  Plant Physiol       Date:  2018-04-05       Impact factor: 8.340

2.  A critical role for topoisomerase IIb and DNA double strand breaks in transcription.

Authors:  Stuart K Calderwood
Journal:  Transcription       Date:  2016-04-21

3.  Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.

Authors:  Gabriele Sulli; Raffaella Di Micco; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Cancer       Date:  2012-09-06       Impact factor: 60.716

4.  Reactive Oxygen Species (ROS)-Activated ATM-Dependent Phosphorylation of Cytoplasmic Substrates Identified by Large-Scale Phosphoproteomics Screen.

Authors:  Sergei V Kozlov; Ashley J Waardenberg; Kasper Engholm-Keller; Jonathan W Arthur; Mark E Graham; Martin Lavin
Journal:  Mol Cell Proteomics       Date:  2015-12-23       Impact factor: 5.911

Review 5.  HMG modifications and nuclear function.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 7.  HMGA proteins as modulators of chromatin structure during transcriptional activation.

Authors:  Nihan Ozturk; Indrabahadur Singh; Aditi Mehta; Thomas Braun; Guillermo Barreto
Journal:  Front Cell Dev Biol       Date:  2014-03-06

8.  The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.

Authors:  Ilenia Pellarin; Laura Arnoldo; Silvia Costantini; Silvia Pegoraro; Gloria Ros; Carlotta Penzo; Gianluca Triolo; Francesca Demarchi; Riccardo Sgarra; Alessandro Vindigni; Guidalberto Manfioletti
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

Review 9.  Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Authors:  Sabine Hombach-Klonisch; Suchitra Natarajan; Thatchawan Thanasupawat; Manoj Medapati; Alok Pathak; Saeid Ghavami; Thomas Klonisch
Journal:  Front Endocrinol (Lausanne)       Date:  2014-03-25       Impact factor: 5.555

10.  Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells.

Authors:  Dario Palmieri; Mario Scarpa; Anna Tessari; Rexhep Uka; Foued Amari; Cindy Lee; Timothy Richmond; Claudia Foray; Tyler Sheetz; Ashley Braddom; Christin E Burd; Jeffrey D Parvin; Thomas Ludwig; Carlo M Croce; Vincenzo Coppola
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.